BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,045 filers reported holding BAXTER INTL INC in Q4 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,359,166 | -12.7% | 26,666 | -7.8% | 0.20% | -18.9% |
| Q3 2022 | $1,557,000 | -21.1% | 28,912 | -5.9% | 0.25% | -14.7% |
| Q2 2022 | $1,973,000 | -16.5% | 30,731 | +0.9% | 0.29% | +1.7% |
| Q1 2022 | $2,362,000 | -9.5% | 30,459 | +0.2% | 0.29% | -3.7% |
| Q4 2021 | $2,610,000 | +8.3% | 30,399 | +1.4% | 0.30% | -0.7% |
| Q3 2021 | $2,411,000 | +3.6% | 29,969 | +3.7% | 0.30% | +4.2% |
| Q2 2021 | $2,327,000 | -9.7% | 28,904 | -5.4% | 0.29% | -13.3% |
| Q1 2021 | $2,576,000 | +5.8% | 30,549 | +0.7% | 0.33% | +2.5% |
| Q4 2020 | $2,435,000 | +2.4% | 30,349 | +2.6% | 0.32% | -9.5% |
| Q3 2020 | $2,379,000 | -6.8% | 29,574 | -0.3% | 0.36% | -11.2% |
| Q2 2020 | $2,553,000 | +2.9% | 29,653 | -3.0% | 0.40% | -10.0% |
| Q1 2020 | $2,482,000 | -9.4% | 30,573 | -6.7% | 0.45% | +17.9% |
| Q4 2019 | $2,739,000 | -3.8% | 32,762 | +0.6% | 0.38% | -9.3% |
| Q3 2019 | $2,848,000 | -1.4% | 32,564 | -7.7% | 0.42% | -0.2% |
| Q2 2019 | $2,888,000 | -6.8% | 35,264 | -7.5% | 0.42% | -9.3% |
| Q1 2019 | $3,099,000 | +24.0% | 38,114 | +0.3% | 0.46% | +7.4% |
| Q4 2018 | $2,500,000 | -14.4% | 37,984 | +0.3% | 0.43% | +3.1% |
| Q3 2018 | $2,919,000 | +3.6% | 37,864 | -0.7% | 0.42% | -1.6% |
| Q2 2018 | $2,817,000 | +14.6% | 38,144 | +1.0% | 0.42% | +12.4% |
| Q1 2018 | $2,458,000 | -2.1% | 37,784 | -2.7% | 0.38% | 0.0% |
| Q4 2017 | $2,510,000 | +2.6% | 38,834 | -0.4% | 0.38% | -11.5% |
| Q3 2017 | $2,446,000 | +3.5% | 38,984 | -0.1% | 0.43% | -0.2% |
| Q2 2017 | $2,363,000 | +16.9% | 39,034 | +0.2% | 0.43% | +13.5% |
| Q1 2017 | $2,021,000 | +18.1% | 38,974 | +1.0% | 0.38% | +12.2% |
| Q4 2016 | $1,711,000 | -4.8% | 38,599 | +2.3% | 0.34% | -4.5% |
| Q3 2016 | $1,797,000 | +5.3% | 37,749 | 0.0% | 0.35% | +2.0% |
| Q2 2016 | $1,707,000 | +13.6% | 37,749 | +3.2% | 0.34% | +7.8% |
| Q1 2016 | $1,502,000 | +13.4% | 36,569 | +5.3% | 0.32% | +10.0% |
| Q4 2015 | $1,325,000 | +24.5% | 34,739 | +7.2% | 0.29% | +20.2% |
| Q3 2015 | $1,064,000 | -48.2% | 32,409 | +10.4% | 0.24% | -43.6% |
| Q2 2015 | $2,053,000 | +1.9% | 29,369 | -0.1% | 0.43% | +3.9% |
| Q1 2015 | $2,014,000 | -4.4% | 29,399 | +2.3% | 0.41% | -6.1% |
| Q4 2014 | $2,107,000 | +39.0% | 28,742 | +36.1% | 0.44% | +10.8% |
| Q3 2014 | $1,516,000 | 0.0% | 21,115 | +0.7% | 0.40% | +1.0% |
| Q2 2014 | $1,516,000 | +1.2% | 20,965 | +2.9% | 0.39% | -1.3% |
| Q1 2014 | $1,498,000 | +8.1% | 20,365 | +2.2% | 0.40% | +5.9% |
| Q4 2013 | $1,386,000 | +13.6% | 19,935 | +7.4% | 0.38% | +4.7% |
| Q3 2013 | $1,220,000 | +4.5% | 18,570 | +10.1% | 0.36% | -0.3% |
| Q2 2013 | $1,167,000 | – | 16,860 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tavio Capital LLC | 68,405 | $5,890,000 | 7.81% |
| Iron Triangle Partners LP | 330,000 | $28,413,000 | 7.16% |
| Veritas Asset Management LLP | 8,942,428 | $769,943,000 | 5.64% |
| TSFG, LLC | 93,405 | $8,042,000 | 5.31% |
| GENERATION INVESTMENT MANAGEMENT LLP | 10,606,094 | $913,185,000 | 5.27% |
| Third Point | 4,000,000 | $344,400,000 | 4.72% |
| Avidity Partners Management LP | 800,900 | $68,957,000 | 4.42% |
| Palmer Knight Co | 62,275 | $5,362,000 | 4.17% |
| Eos Focused Equity Management, L.P. | 36,786 | $3,167,000 | 3.70% |
| Dundas Partners LLP | 196,133 | $16,887,000 | 3.69% |